-
1
المؤلفون: Takeshi Tsutsumi, Yuya Fujiwara, Naokazu Ibuki, Ryoichi Maenosono, Teruo Inamoto, Haruhito Azuma, Taizo Uchimoto, Hirofumi Uehara, Shin Egawa, Takahiro Kimura, Tomohito Tanaka, Kiyoshi Takahara, Takuya Tsujino, Wataru Fukuokaya, Kazumasa Komura, Tomohisa Matsunaga, Kohei Taniguchi, Yuki Yoshikawa, Hayahito Nomi, Kazuhiro Takahashi, Hajime Hirano
المصدر: BJU International. 127:212-221
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Urology, Decision Making, Antineoplastic Agents, Risk Assessment, Disease-Free Survival, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Japan, Internal medicine, medicine, Overall survival, Humans, Enzalutamide, 030212 general & internal medicine, Aged, business.industry, medicine.disease, Survival Rate, Prostatic Neoplasms, Castration-Resistant, Abiraterone, chemistry, Docetaxel, 030220 oncology & carcinogenesis, Risk stratification, Cohort, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0affbe7dff12027c8a7f5b5bb7bdb4b8Test
https://doi.org/10.1111/bju.15187Test -
2
المؤلفون: Hirokazu Abe, Takahiro Kimura, Yuya Iwamoto, Yuhei Koike, Takafumi Yanagisawa, Yuki Enei, Shin Egawa, Masatoshi Tanaka, Mariko Honda, Wataru Fukuokaya, Hajime Onuma, Yu Oyama, Jun Miki, Fumihiko Urabe, Shunsuke Tsuzuki, Shoji Kimura
المصدر: BJU International. 127:90-95
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Organoplatinum Compounds, Urology, medicine.medical_treatment, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, medicine, Humans, 030212 general & internal medicine, Response Evaluation Criteria in Solid Tumors, Aged, Proportional Hazards Models, Retrospective Studies, Carcinoma, Transitional Cell, Proportional hazards model, business.industry, Hazard ratio, Retrospective cohort study, Immunotherapy, medicine.disease, Confidence interval, Survival Rate, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, Retreatment, Disease Progression, Female, business, Progressive disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763de6a45a44caccda57b5dc91934b84Test
https://doi.org/10.1111/bju.15176Test